NICE recommends semaglutide for obesity Prescribers will be able to offer semaglutide (Wegovy) for weight loss in the NHS, after NICE recommended the GLP-1 agonist for use in specialist weight management services
Director, Clinical Account Management, LucyRx Maggie Scott , VP, Strategic Solutions, Personify Health Dr
Research suggests that glutathione is the primary defender against this process
References Latif W, Lambrinos KJ, Rodriguez R
Mitochondrial outer membrane protein FUNDC2 promotes ferroptosis and contributes to doxorubicin-induced cardiomyopathy
If you want to learn more about the ingredient itself, our What is Glutathione and Why It Matters for Our Health guide is a great next read